Zoledronate in the prevention of Paget(cid:146)s (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1 mediated Paget(cid:146)s disease of bone
暂无分享,去创建一个
S. Lewis | M. Boers | S. Ralston | M. Brandi | M. Porteous | E. Duncan | M. Seibel | J. Walsh | W. Fraser | J. Tobias | M. Stefano | R. Cetnarskyj | G. Murray | J. Devogelaer | L. Ranganath | R. Nuti | J. Blanch | M. Kotowicz | G. Nicholson | R. Russell | P. Selby | L. Gennari | N. Guañabens | A. Horne | G. Isaia | G. Major | K. Goodman | R. Crowley | S. Young-Min | N. Gilchrist | C. Keerie | M. McKenna | G. Hampson | A. Walker | L. Forsyth | A. Durnez | J. Pino-Montes | R. Chandra | Keith Charnock | D. Wilkinson | Shu-An Ho | Laura Forsyth | J. pino-Montes | J. Walsh